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Abstract
Introduction
The digitalization of medicine has led to a considerable growth of heterogeneous health
datasets, which could improve healthcare research if integrated into the clinical life cycle.
This process requires, amongst other things, the harmonization of these datasets, which is
a prerequisite to improve their quality, re-usability and interoperability. However, there is a
wide range of factors that either hinder or favor the harmonized collection, sharing and link-
age of health data.
Objective
This systematic review aims to identify barriers and facilitators to health data harmonization—
including data sharing and linkage—by a comparative analysis of studies from Denmark and
Switzerland.
Methods
Publications from PubMed, Web of Science, EMBASE and CINAHL involving cross-institu-
tional or cross-border collection, sharing or linkage of health data from Denmark or Switzer-
land were searched to identify the reported barriers and facilitators to data harmonization.
Results
Of the 345 projects included, 240 were single-country and 105 were multinational studies.
Regarding national projects, a Swiss study reported on average more barriers and facilita-
tors than a Danish study. Barriers and facilitators of a technical nature were most frequently
reported.
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Conclusion
This systematic review gathered evidence from Denmark and Switzerland on barriers and
facilitators concerning data harmonization, sharing and linkage. Barriers and facilitators
were strictly interrelated with the national context where projects were carried out. Structural
changes, such as legislation implemented at the national level, were mirrored in the projects.
This underlines the impact of national strategies in the field of health data. Our findings also
suggest that more openness and clarity in the reporting of both barriers and facilitators to
data harmonization constitute a key element to promote the successful management of new
projects using health data and the implementation of proper policies in this field. Our study
findings are thus meaningful beyond these two countries.
Introduction
Technological advances made over the past few years have increased the digitalization of medi-
cine, thus leading to a considerable growth of clinical, research and public health datasets.
These data sources are increasingly related to the big data environment and they include,
amongst others, genomics and other-omics related-data collections, electronic health records
(EHRs), patient registries, medical imaging, administrative data and clinical trials data [1, 2].
However, a good part of such datasets are often kept and analysed in silos and not adequately
shared [3]. If properly integrated into the clinical life cycle, such collections of data stand to
offer a unique opportunity to drive scientific discoveries and improve healthcare research. For
example, they may allow a better understanding of the aetiology of illnesses and subsequently
help in improving the management, prevention and treatment of diseases [1, 2]. This is even
more promising in the framework of learning healthcare systems, where clear boundaries
between research and care are dissolving and the same data are used both for improving scien-
tific knowledge and providing better care [4].
In this context, developing the harmonization of health data—described as the sum of all
“efforts to combine data from different sources and provide users with a comparable view of
data from different studies” [5]—is crucial to improve clinical research and practice. Such
standardized approach requires not only better quality, re-usability and interoperability of
data, but also more open and collaborative communication between the different stakeholders
active in the health data environment [6]. The fact that a good percentage of healthcare spend-
ing are being wasted as a consequence of under-exploiting data potential in several healthcare
systems around the world [7–9] should be considered as one important factor urging for such
changes to happen. Harmonized health datasets are also laying the foundation of a new era of
biomedical research, where three concepts are currently converging, namely precision medi-
cine, learning healthcare systems and implementation science [7, 10].
The harmonization of health data is a complex procedure which involves significant
changes in how data are collected, shared and linked. Harmonization can be either prospec-
tive, when modifications occur in the study design to subsequently render the pooling of data
more straightforward, or retrospective, when pooling is performed with data collected previ-
ously according to different study designs [11]. In practical terms, harmonization can be
achieved through two distinct but complementary approaches, namely a “stringent” and a
“flexible one” [12]. By means of a “stringent” approach, data are harmonized through the use
of standard collection tools and standard operating procedures, implementable only in a
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prospective way. With the “flexible” approach, on the contrary, different data collection tools
might be used, as long as operating procedures are standardized [12].
In achieving the harmonization of health data, careful consideration needs to be given to
already well-known as well as novel challenges related to the processes of collection, sharing
and linkage. Such challenges are drastically intensified by the vastness and the hyper-connect-
edness of data at present time [13], which may result in unforeseen connections or cross-
referencing between datasets, drastically increasing re-identification risks for data subjects
[14]. The presence of these challenges has resulted in the emerging of several barriers to the
effective use and sharing of health-related data [2, 15]. Although these have been categorized
as technical, motivational, economic, political, socio-cultural, ethical and legal [1, 2, 15–17], a
more precise mapping of the exact content of such barriers, and of the solutions that have been
elaborated to mitigate them, is lacking.
Within this framework, the aim of this systematic review is to identify more precisely some
of the barriers and facilitators encountered in the effort to achieve harmonization of health
data—including the processes of data sharing and linkage—by a comparative analysis of stud-
ies conducted in two countries having different healthcare systems and data infrastructures,
namely Denmark and Switzerland. These countries where chosen because, although they both
offer high quality healthcare, they have two very diverse healthcare systems and two different
data infrastructure models for healthcare. Denmark has a Beveridge-based national healthcare
system [18] and a long tradition of data linkage in health through its nationwide registries
[19]. On the contrary, Switzerland is based on a federalist Bismarckian organization of health-
care [20, 21] and started much later to develop strategies in the field of Health Information
Exchange [22]. In this perspective, this review seeks to identify past and current studies related
to the field of harmonized health data collection, sharing and linkage in these two countries
and list the barriers encountered and the facilitators that make these projects successful. Fur-
thermore, the review aims to provide some insights on the complexities associated with the use
of health data that can be of relevance also in the broader international context.
Methodology
Search strategy and study selection
This study conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Anal-
ysis (PRISMA) guidelines [23], and its protocol was registered on January 3rd 2018 on PROS-
PERO (CRD42018081424). A systematic literature search was performed on four search
engines and electronic bibliographic databases namely PubMed, Web of Science (all databases),
EMBASE (no Medline) and CINAHL for publications with dates ranging from 1st January 2008
to 31st December 2017. The time period is aligned with the adoption of the Swiss national
eHealth Strategy in 2007, with the aim of introducing electronic patient records at national level
[24]. The search was repeated for the period of 1st January 2018 to 31st March 2019 to include
additional publications and to ensure that our systematic review is up-to-date. Reference lists of
included publications were screened to identify other potential harmonized health data collec-
tion, sharing or linkage projects. A search strategy was developed for each electronic database.
The literature search included Medical Subject Headings (MeSH) terms and free applicable text
to health data collection, sharing and linkage. The search strategy consisted of three compo-
nents, namely (1) types of health data, (2) keywords for data collection, sharing and linkage and
(3) country of interest. For instance, the search strategy for Switzerland on PubMed was:
("Administrative Claims, Healthcare"[Mesh] OR "Health Records, Personal"[Mesh] OR "Clini-
cal Coding"[Mesh] OR "Patient Discharge Summaries"[Mesh] OR "Clinical Trials as Topic"[-
Mesh]) AND ("Databases as Topic"[Mesh] OR "Data Collection"[Mesh] OR "Medical
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Informatics"[Mesh] OR "Medical Record Linkage"[Mesh] OR "Information Dissemination"[-
Mesh] OR "Data Integration" OR "Data Sharing") AND ("Switzerland"[Mesh]) [filters used are
Articles types (Clinical Study, Clinical Trials (including controlled and Phases I to IV), Compar-
ative Study, Evaluation Studies, Journal Article, Multicenter Study, Observational Study, Prag-
matic Clinical Trial, Randomized Control Trial, Technical Report and Validation Studies),
language (Danish, English, French and German) and species (Human Studies)]. We did not
include harmonization as an imperative component in our search strategy since the exact
boundaries of this concept are still controversial [25] and the addition of the term “harmoniza-
tion” as an imperative component drastically reduced the number of publications for each
country.
Eligibility criteria for this study were: (i) publications based on health data collection, shar-
ing or linkage projects. There was no restriction on study design and type, i.e. qualitative,
quantitative or mixed method studies, and clinical or observational studies were included; sys-
tematic reviews were excluded; (ii) there were no restriction on age, gender, disease and ethnic
group of participants involved in these studies; (iii) the studies had to involve some health data
collection, sharing or linkage at cross-institutional, cross-national or cross-regional levels in at
least one of the two countries; (iv) only English, French, German and Danish language articles
were included, and (v) publication year of articles ranged from January 2008 to March 2019.
Data extraction and quality assessment
The literature search results were catalogued on EndNoteTM X8, a reference manager software.
The titles and abstracts of all articles were screened independently by two authors (LDG and
AM). The full-texts of the included publications were reviewed by LDG and AM to ensure that
they met the eligibility criteria to be included in the systematic review. LDG and AM per-
formed independently the data extraction from the included articles through a standard data
extraction form developed progressively by the authors of this review. Additional publications
gathered through reference screening went through title and abstract, and independent full-
text screenings and data extraction by MCM. Another review author, TW, validated randomly
twenty percent of the publications reviewed by LDG, AM and MCM, to assess the quality of
the data extraction process. A disagreement level of less than 10% for the data entries was con-
sidered acceptable.
The data extraction form included (i) study information (author(s) and publication year),
(ii) sources of health data, (iii) cross-institutional or cross-national nature of the study, (iv)
presence or absence of primary and secondary health data collection, analysis and sharing, and
lastly (v) the categorization of barriers and facilitators to harmonized health data collection,
sharing and linkage. The sources of health data were categorized as having three standard ori-
gins, namely health services, public health and research [26]. Other sources of health data fall-
ing outside these three categories were classified in a residual category (“Other”).
LDG and AM performed a categorization of the identified barriers and facilitators sepa-
rately, and came to consensus on the final categorization of these elements for accuracy and
inclusiveness. Disagreements were solved with the mediation of TW. The identified barriers
and facilitators to harmonized health data collection, sharing and linkage were subsequently
clustered into main categories, which were then sub-clustered into smaller categories to high-
light the most common barriers and facilitators in these main categories (the full clustering/
sub-clustering of barriers and facilitators is shown in Table 1). For the purpose of this system-
atic review, we defined harmonization techniques as methods which would allow the coherent
pooling of different data sources, involving health data collected either prospectively, retro-
spectively or both. Examples include the use of standard case report forms or data dictionaries,
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a central review of the collected data, training provided to researchers/stakeholders and leader-
ship role by one of the partners for coordinating data collection, sharing or linkage activities.
Analysis
A narrative synthesis of included publications was carried out [27]. This step involved the cate-
gorization of health data collection, sharing and linkage projects based on their national or
cross-national dimension, their source of health data, and barriers and facilitators identified in
these publications. This step was important to highlight similarities and differences between
projects in Denmark and Switzerland. The statistical software, STATA1 version 15.0, was
used for the different analyses.
Results
A total of 1928 papers were initially retrieved from the search engines and electronic biblio-
graphic databases for the period of January 2008 to December 2017. The search was repeated
Table 1. Clustering of barriers and facilitators to harmonized health data collection, sharing and linkage.
Barriers Facilitators
Cluster Sub-cluster Cluster Sub-cluster
Ethical Privacy Ethico-Legal Ethical approval by REC/IRB
Respect for Autonomy Health Data Anonymization
Other Informed Consent
Legal Data Protection Regulations Patient data access rights
Divergence in National Legislations for Data Security and Privacy Confidentiality measures
Other Clarity of legislation for health data collection/sharing/linkage
Official/legal approval of project
Study according to International laws and regulations
Legislation allows project without consent or REC approval
Legislation requires mandatory reporting
Other
Technical Lack of Data Standards (data structure and semantics) Technical Data harmonization techniques
Data Quality Issues Data Linkage techniques
Limited Technical Capabilities
Other Other
Financial Lack of Funding Financial Securing funding
Other Public-Private partnership
Other
Political Mistrust between stakeholders Political Data Sharing Agreement
Data Ownership Building and maintaining stakeholder trust
Institutional/constitutional organization issues Data access control
Other Health System Structure
Other
Motivational Lack of research incentives Motivational Monetary Incentive
Stakeholder restricts access for re-use of data as deemed unfit for
secondary use
Easing workload through improvement of data collection
Stakeholder competing interests Memorandum of understanding to ensure collaboration until
end of study
Other Other
Sociocultural Cultural clash for data collection/sharing/linkage Sociocultural Participant data access control
Other Other
https://doi.org/10.1371/journal.pone.0226015.t001
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for the period of January 2018 to March 2019 (upon request of the journal) resulting in a total
of 425 additional papers. The result of the two searches were combined for each stage of the
PRISMA resulting in an overall total of 2353 papers retrieved for the period of January 2008 to
March 2019 (Fig 1). Duplicates (n = 170) were removed either automatically using ENDNOTE
X8 or manually after reviewing abstracts and their titles. The remaining 2183 papers went
through title and abstract screening, which resulted in the exclusion of 1789 papers. In-depth
full-text screening was performed for 394 papers, and 115 more papers were excluded for not
meeting the inclusion criteria (see Fig 1 for reasons). Reference screening of the 279 included
papers, resulted in the identification and inclusion of 66 additional papers which met the eligi-
bility criteria for this systematic review (Fig 1).
The 345 included papers are summarized in Table 2, where they are categorized based on
their national (n = 240) or cross-national (n = 105) dimension, their sources of health data and
the total number of barriers and facilitators reported for each project. We identified 200 Dan-
ish and 40 Swiss national projects, and 105 cross-national projects. Among these cross-
national projects, 14 projects involved the use of health data from both Denmark and Switzer-
land, 51 and 40 projects involved a Danish partner and a Swiss partner respectively. Overall,
the number of projects which involved primary health data collection, sharing and analysis
were 106 (30.7%), 92 (26.7%) and 106 (30.7%) respectively. Comparatively, the number of
projects which involved secondary health data collection and analysis were 283 (82.0%; if a
study collected both primary health data and secondary health data, it was counted for both).
Of the 345 projects, 199 used health data from health services, 211 from public health sector,
94 from research and 62 from other health data sources.
Fig 1. Flow diagram of study selection.
https://doi.org/10.1371/journal.pone.0226015.g001
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Table 2. Characteristics of included projects (n = 345) with the total number of identified barriers and facilitators per project.
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Aabakke et al. 2014 [28] DKa National Health Services; Public Health; Other 4 5
Adam et al. 2010 [29] CHb National Research 5 7
Agergaard et al. 2017 [30] DK National Health Services 3 6
Agten et al. 2017 [31] CH National Public Health 1 3
Ammundsen et al. 2012 [32] DK National Health Services; Research 3 6
Andersen et al. 2011 [33] DK National Health Services; Public Health 4 8
Andersen et al. 2014 [34] DK National Health Services, Public Health 2 4
Andres et al. 2018 [35] CH National Public Health 4 3
Annaheim et al. 2018 [36] CH National Health Services; Other 5 3
Antonsen et al. 2011 [37] DK National Public Health; Research 2 2
Antonsen et al. 2016 [38] DK National Health Services; Public Health; Research 2 12
Arboe et al. 2016 [39] DK National Health Services; Public Health; Other 0 14
Arking et al. 2014 [40] CH Cross-national Research 0 4
Atlado´ttir et al. 2012 [41] DK National Health Services; Public Health; Other 1 4
Aubert et al. 2016 [42] CH National Health Services 0 5
Auer et al. 2014[43] CH National Health Services; Public Health 0 9
Avillach et al. 2013 [44] DK Cross-national Health Services; Public Health 5 12
Avlund et al. 2018 [45] DK National Health Services; Public Health 1 8
Bachelet et al. 2016 [46] DK Cross-national Health Services; Public Health; Research 2 7
Baker et al. 2009 [47] DK National Health Services 3 2
Baldur-Felskov et al. 2013 [48] DK National Health Services; Research 2 5
Balgobind et al. 2009 [49] DK Cross-national Health Services; Research 0 1
Bay-Nielsen et al. 2008 [50] DK National Public Health 0 2
Beduneau et al. 2017 [51] CH Cross-national Health Services; Public Health 1 6
Begre et al. 2010 [52] CH National Other 2 4
Bendixen et al. 2019 [53] DK National Health Services; Public Health; Research;
Other
0 3
Beretta-Piccoli et al. 2017 [54] CH National Health Services; Public Health 3 8
Binderup et al. 2018 [55] DK National Health Services; Research; Other 2 5
Bisgaard et al. 2013 [56] DK National Health Services; Research 0 5
Bjerregaard and Larsen 2011 [57] DK National Health Services; Public Health 0 11
Bjornholt et al. 2015 [58] DK National Health Services; Public Health; Research 1 9
Blaha et al. 2016 [59] DK Cross-national Health Services 2 6
Blenstrup and Knudsen 2011 [60] DK National Health Services; Research 1 3
Blichert-Toft et al. 2008 [61] DK National Health Services; Public Health; Research 0 3
Bodin et al. 2018 [62] DK Cross-national Health Services; Public Health 3 6
Boje et al. 2014 [63] DK National Public Health 1 3
Brenner et al. 2011 [64] CH National Public Health 1 6
Brink et al. 2018 [65] DK National Research 5 6
Burgstaller et al. 2016 [66] CH National Health Services; Research 0 6
Cainzos-Achirica et al. 2018 [67] DK Cross-national Health Services 4 5
Calhaz-Jorge et al. 2017 [68] DK Cross-national Public Health; Other 2 4
Calvet et al. 2014 [69] CH Cross-national Research 2 3
Carstensen et al. 2008 [70] DK National Health Services 0 4
Caspersen et al. 2008 [71] DK National Health Services; Public Health 0 7
Chaigne et al. 2017[72] CH National Health Services 0 5
Chesnaye et al. 2014 [73] DK Cross-national Public Health 1 2
(Continued)
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Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Chmiel et al. 2011 [74] CH National Health Services 3 10
Christensen et al. 2011 [75] DK National Health Services; Public Health; Research 0 2
Christensen et al. 2011b [76] DK National Public Health 0 11
Christensen et al. 2011c [77] DK National Health Services; Public Health 1 5
Christensen et al. 2014 [78] DK National Health Services; Public Health; Other 1 8
Christensen et al. 2016 [79] DK National Public Health 1 6
Christensen et al. 2016b [80] DK National Health Services; Public Health 1 6
Christiansen et al. 2008 [81] DK National Public Health; Research 1 5
Christiansen et al. 2008b [82] DK National Health Services; Public Health 1 3
Christoffersen et al. 2015 [83] DK National Health Services; Public Health; Other 1 5
Coleman et al. 2011 [84] DK Cross-national Public Health 2 13
Coloma et al. 2011 [85] DK Cross-national Health Services 5 9
Corraini et al. 2017 [86] DK National Public Health 1 6
Costantino et al. 2018 [87] DK Cross-national Health Services; Other 4 6
Cotter et al. 2013 [88] CH Cross-national Health Services; Research 1 3
Czauderna et al. 2016 [89] CH Cross-national Research 4 9
Dalgard et al. 2010 [90] DK Cross-national Research 0 0
Damgaard et al. 2013 [91] DK National Public Health 1 3
Darby et al. 2013 [92] DK Cross-national Health Services; Public Health 1 4
Dastani et al. 2012 [93] CH Cross-national Research 0 4
De Angelis et al. 2009 [94] Both Cross-national Research 5 7
De Groot et al. 2014 [95] DK Cross-national Health Services; Public Health; Research 4 1
della Torre et al. 2012 [96] CH National Health Services 0 5
Dencker et al. 2016 [97] DK National Public Health 1 1
De Vos Andersen et al. 2017 [98] DK National Health Services; Public Health; Other 2 9
Diel et al. 2010 [99] CH National Health Services 3 7
Disanto et al. 2016 [100] CH National Public Health 0 11
Donia et al. 2017 [101] DK National Public Health; Research 2 0
Downs et al. 2016 [102] DK Cross-national Public Health; Other 1 2
Dreyer et al. 2015 [103] DK Cross-national Public Health; Other 2 7
Edgren et al. 2015 [104] DK Cross-national Health Services; Public Health; Other 1 6
Ehlers et al. 2009 [105] DK National Public Health; Other 0 3
Ekelund et al. 2015 [106] DK National Health Services; Public Health 1 12
El-Galaly et al. 2015 [107] DK Cross-national Public Health 1 5
Elliott et al. 2017 [108] DK National Health Services 1 2
Engelberger et al. 2015 [109] CH National Health Services; Public Health 0 6
Erdem et al. 2015 [110] DK Cross-national Health Services; Other 1 2
Erichsen et al. 2010 [111] DK National Health Services; Public Health; Research 0 13
Erichsen et al. 2011 [112] DK National Health Services; Public Health 1 4
Erlangsen et al. 2008 [113] DK National Public Health 1 5
Escala-Garcia et al. 2019 [114] DK Cross-national Research 2 2
Escott-Price et al. 2014 [115] CH Cross-national Research 0 0
Fago¨-Olsen et al. 2012 [116] DK National Public Health 0 1
Fahrner et al. 2014 [117] CH National Health Services 4 2
Fedder et al. 2013 [118] DK National Public Health 2 5
Fenger et al. 2016 [119] DK National Public Health; Other 1 5
(Continued)
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Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Fieten et al. 2018 [120] CH Cross-national Research 3 3
Fløe et al. 2018 [121] DK National Health Services; Other 1 4
Frandsen et al. 2014 [122] DK National Health Services; Public Health 2 5
Frary et al. 2016 [123] DK National Health Services; Public Health 0 5
Freiberg et al. 2017 [124] Both Cross-national Health Services; Public Health 0 3
Friis et al. 2009 [125] DK National Health Services; Public Health; Other 1 4
Funcke et al. 2016 [126] CH Cross-national Health Services; Public Health 1 7
Furtwa¨ngler et al. 2018 [127] CH Cross-national Health Services; Research 1 4
Gammelager et al. 2012 [128] DK National Health Services; Public Health 1 7
Garcia-Etienne et al. 2019 [129] CH Cross-national Health Services 1 4
Gatta et al. 2017 [130] CH Cross-national Research 1 1
Gatzioufas et al. 2016 [131] CH Cross-national Research 0 4
Geissbuhler 2013 [132] CH National Health Services 16 15
Ghith et al. 2012 [133] DK National Research; Other 2 7
Gjerstorff 2011 [134] DK National Public Health 1 7
Glintborg et al. 2011 [135] DK National Health Services; Public Health 2 5
Godballe et al. 2009 [136] DK National Public Health 0 5
Gorski et al. 2015 [137] CH Cross-national Research 1 6
Goutaki et al. 2017 [138] Both Cross-national Health Services 2 14
Goutaki et al. 2019 [139] CH National Health Services; Research 4 10
Gradel et al. 2008 [140] DK National Health Services; Public Health 0 5
Grann et al. 2011 [141] DK National Health Services; Public Health 1 6
Gratwohl et al. 2015 [142] CH Cross-national Research 0 4
Gregersen et al. 2016 [143] DK National Public Health 3 6
Griffin et al. 2011 [144] DK Cross-national Health Service; Research; Other 2 3
Gromov et al. 2014 [145] DK National Health Services 0 5
Gruber et al. 2018 [146] CH Cross-national Health Services 0 2
Gudbrandsdottir et al. 2012 [147] DK National Health Services; Other 1 1
Gulmez et al. 2009 [148] DK National Health Services; Public Health 0 4
Gylvin et al. 2017 [149] DK National Health Services; Research; Other 1 3
Hallas et al. 2012 [150] DK National Health Services; Public Health 3 6
Hallas and Pottegard 2017 [151] DK National Health Services; Public Health 1 5
Halmin et al. 2017 [152] DK Cross-national Public Health 0 4
Hansen et al. 2008 [153] DK National Health Services; Public Health 1 8
Hansen et al. 2012 [154] DK National Health Services; Public Health 2 4
Hansen and Jacobsen 2014 [155] DK National Health Services; Research 1 6
Hansen et al. 2018 [156] DK National Health Services; Research; Other 2 4
Harshman et al. 2012 [157] DK Cross-national Health Services; Public Health 1 2
Hatz et al. 2011 [158] CH National Public Health 1 6
Haueis et al. 2012 [159] CH Cross-national Research 1 4
Havelin et al. 2009 [160] DK Cross-national Public Health 3 6
Head et al. 2013 [161] DK Cross-national Health Services; Other 3 5
Helgstrand et al. 2010 [162] DK National Health Services; Public Health 0 7
Helgstrand et al. 2012 [163] DK National Health Services; Public Health; Other 0 3
Helqvist et al. 2012 [164] DK National Health Services; Public Health 0 3
Helweg-Larsen 2011 [165] DK National Public Health; Other 1 3
(Continued)
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Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Hemkens et al. 2017 [166] CH National Research 0 5
Henningsen et al. 2011 [167] DK National Public Health 0 4
Henningsen et al. 2011b [168] DK Cross-national Public Health 4 8
Henriksen et al. 2013 [169] DK National Public Health 0 3
Herzberg et al. 2012 [170] DK National Health Services 1 3
Hetland 2011 [171] DK National Health Services; Other 5 16
Holland-Bill et al. 2014 [172] DK National Health Services; Public Health 1 8
Horsdal et al. 2012 [173] DK National Health Services; Public Health 2 5
Hyldig et al. 2019 [174] DK National Health Services; Public Health; Research;
Other
1 5
Ingeholm et al. 2016 [175] DK National Health Services; Public Health; Other 2 6
Ittermann et al. 2018 [176] DK Cross-national Research 1 4
Iversen et al. 2016 [177] DK National Public Health 1 8
Jacobs et al. 2014 [178] CH Cross-national Research 0 11
Jakobsen et al. 2017 [179] DK National Public Health 2 2
Jensen et al. 2009 [180] DK National Health Services; Public Health 1 6
Jensen et al. 2010 [181] DK National Health Services; Public Health 1 0
Jensen et al. 2011 [182] DK National Health Services 2 6
Jensen et al. 2016 [183] DK National Public Health 1 7
Jensen et al. 2017 [184] DK National Public Health 1 1
Jeppesen et al. 2016 [185] DK National Health Services; Public Health 2 5
Johannesdottir et al. 2012 [186] DK National Health Services; Public Health 3 9
Jørgensen et al. 2018 [187] DK National Health Services; Public Health 1 6
Joshi et al. 2015 [188] Both Cross-national Research 1 6
Kachuri et al. 2018 [189] DK Cross-national Research 0 2
Kaltoft et al. 2009 [190] DK National Health Services; Public Health 2 3
Karkov et al. 2010 [191] DK National Health Services; Public Health; Other 2 5
Kent et al. 2015 [192] DK National Health Services; Public Health; Other 1 13
Khanna et al. 2008 [193] CH National Research 1 1
Khatami et al. 2016 [194] Both Cross-national Health Services 2 14
Kiderlen et al. 2012 [195] CH Cross-national Public Health 3 2
Kildemoes et al. 2011 [196] DK National Health Services; Public Health 1 8
Kirwan et al. 2008 [197] Both Cross-national Research 2 12
Klein et al. 2012 [198] DK National Health Services; Public Health 1 1
Knudsen et al. 2013 [199] DK National Health Services 0 1
Kowalska et al. 2011 [200] DK Cross-national Health Services; Other 4 4
Kronborg et al. 2009 [201] DK National Public Health; Other 1 6
Laenkholm et al. 2018 [202] DK National Health Services; Public Health 0 8
Laguna et al. 2009 [203] CH Cross-national Health Services 0 3
Landolt et al. 2016 [204] CH Cross-national Research 0 3
Lang et al. 2019 [205] CH Cross-national Research 2 3
Lange et al. 2017 [206] DK National Health Services; Other 0 5
Laouali et al. 2018 [207] DK Cross-national Public Health; Other 1 6
Larsen et al. 2016 [208] DK National Public Health; Research 2 3
Larsen et al. 2016b [209] DK National Health Services; Public Health 3 5
Laursen et al. 2018 [210] DK National Health Services; Public Health; Research 1 5
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Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Leboeuf-Yde et al. 2012 [211] DK National Research; Other 1 1
Lehnert et al. 2018 [212] DK National Public Health 1 3
Lildballe et al. 2014 [213] DK National Health Services; Public Health 0 2
Linauskas et al. 2018 [214] DK National Public Health 7 4
Lindhardsen et al. 2011 [215] DK National Health Services 1 7
Lindhardsen et al. 2012 [216] DK National Health Services; Other 2 8
Linnet et al. 2009 [217] DK National Health Services; Public Health; Other 2 7
Liu et al. 2016 [218] DK National Health Services; Public Health; Research 1 7
Lund et al. 2018 [219] DK National Public Health 4 8
Lundstrøm et al. 2009 [220] DK National Public Health 3 5
Luta et al. 2018 [221] CH National Research 0 6
Lydiksen et al. 2014 [222] DK National Health Services; Public Health 0 3
Lynge et al. 2011 [223] DK National Health Services 3 4
Maeng et al. 2008 [224] DK National Health Services; Public Health 1 4
Mahajan et al. 2018 [225] DK Cross-national Research 2 6
Majholm et al. 2012 [226] DK National Health Services; Public Health 3 3
Mareri et al. 2011 [227] Both Cross-national Research 0 4
Margulis et al. 2017 [228] DK Cross-national Public Health 2 5
May et al. 2014 [229] CH Cross-national Research 3 6
Mejdahl et al. 2013 [230] DK National Public Health; Other 2 3
Mellernkjær et al. 2014 [231] DK National Health Services; Public Health 0 1
Messerli et al. 2016 [232] CH National Public Health; Research 0 6
Mikkelsen et al. 2015 [233] DK National Health Services; Other 2 4
Minnerup et al. 2015 [234] CH Cross-national Health Services 0 1
Modvig et al. 2017 [235] DK National Public Health 0 5
Mo¨hring et al. 2019 [236] CH Cross-national Research 1 7
Møller et al. 2008 [237] DK National Public Health 2 6
Mors et al. 2011 [238] DK National Health Services; Public Health 0 9
Mortensen et al. 2011 [239] DK National Public Health; Research 1 3
Mortensen et al. 2013 [240] DK National Health Services; Public Health 0 2
Mueller et al. 2015 [241] CH Cross-national Research 0 7
Mukai et al. 2013 [242] DK National Health Services; Public Health 1 2
Mu¨ller et al. 2012 [243] CH National Other 1 4
Munk et al. 2012 [244] DK National Public Health; Other 0 6
Narath et al. 2016 [245] CH Cross-national Health Services; Research 0 7
Neelon et al. 2015[246] DK National Public Health 1 2
Nickenig et al. 2014 [247] Both Cross-national Health Services; Public Health 2 4
Nielsen et al. 2012 [248] DK National Health Services; Public Health 1 3
Nielsen et al. 2015 [249] DK National Health Services; Public Health 2 2
Nielsen et al. 2015b [250] DK National Health Services; Public Health 2 3
Nielsen and Nordestgaard 2016
[251]
DK National Health Services; Public Health; Other 1 3
Nilsson et al. 2014 [252] DK National Health Services; Public Health 3 5
Nolan-Kenney et al. 2019 [253] CH Cross-national Research 4 8
Nørskov et al. 2015 [254] DK National Public Health 1 4
Nørskov et al. 2017 [255] DK National Public Health; Research 1 4
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Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Nyholm et al. 2015 [256] DK National Health Services; Public Health 2 3
Olsen et al. 2008 [257] DK National Health Services; Public Health; Other 3 4
Olsen et al. 2013 [258] DK National Public Health 1 5
Orsted et al. 2011[259] DK National Public Health 2 5
O¨zcan et al. 2016 [260] DK National Health Services 2 10
Pacurariu et al. 2015 [261] DK Cross-national Public Health 5 2
Pagh et al. 2013 [262] DK National Health Services; Other 1 2
Palnum et al. 2012 [263] DK National Health Services; Public Health; Other 2 6
Pasternak et al. 2014 [264] DK National Health Services; Public Health 1 5
Patadia et al. 2018 [265] DK Cross-national Health Services; Research 1 2
Pattaro et al. 2016 [266] Both Cross-national Research 1 7
Paulsen et al. 2013 [267] DK National Public Health 1 6
Pechmann et al. 2019 [268] CH Cross-national Research 1 12
Pedersen et al. 2010 [269] DK Cross-national Health Services 0 2
Pedersen 2011 [270] DK National Health Services; Public Health 2 6
Pedersen et al. 2011 [271] DK National Health Services; Public Health 0 4
Perera et al. 2018 [272] DK Cross-national Public Health 3 1
Perregaard et al. 2015 [273] DK National Public Health 2 3
Petersen et al. 2018 [274] DK National Public Health 3 2
Petersen et al. 2018b [275] DK National Health Services; Public Health; Other 1 3
Piazza et al. 2010 [276] CH Cross-national Health Services 0 1
Piltoft et al. 2017 [277] DK National Public Health; Other 0 4
Pinborg et al. 2015 [278] DK National Public Health 0 4
Pironi et al. 2017 [279] DK Cross-national Health Services 2 5
Plu¨ss-Suard et al. 2013 [280] CH National Health Services 1 3
Pommergaard et al. 2014 [281] DK National Health Services; Public Health 3 3
Pottegard et al. 2014 [282] DK National Public Health 0 9
Pottegard et al. 2015 [283] DK National Public Health 2 6
Poulsen et al. 2012 [284] DK National Health Services 2 4
Poulsen et al. 2016 [285] DK National Health Services; Public Health 1 4
Poulsen et al. 2018 [286] DK National Health Services; Public Health 1 6
Preston et al. 2014 [287] DK National Public Health 0 5
Prins et al. 2018 [288] DK Cross-national Research 0 6
Pukkala et al. 2009 [289] DK Cross-national Public Health 2 6
Radovanovic and Erne 2010 [290] CH National Health Services 3 12
Ramlau-Hansen et al. 2009 [291] DK National Health Services; Public Health 2 3
Rasmussen et al. 2012 [292] DK National Public Health 1 2
Rasmussen and Tønnesen 2016
[293]
DK National Public Health; Other 1 7
Rasmussen et al. 2017 [294] DK National Public Health; Other 2 7
Rathe 2015 [295] DK National Health Services; Public Health 0 7
Reyes et al. 2016 [296] DK Cross-national Public Health 0 4
Ringdal et al. 2011 [297] Both Cross-national Research; Other 6 8
Roberto et al. 2016 [298] DK Cross-national Health Services; Public Health; Research 2 8
Rudin et al. 2008 [299] CH National Research 0 5
Rungby et al. 2017 [300] DK National Health Services; Public Health 2 6
(Continued)
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Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Russell et al. 2018 [301] DK Cross-national Research 2 5
Schaefer et al. 2013 [302] CH National Health Services 0 4
Scha¨fer et al. 2018 [303] CH Cross-national Research; Other 2 6
Schatlo et al. 2012 [304] CH National Health Services; Research 0 4
Schatorje´ et al. 2014 [305] CH Cross-national Research 4 6
Schmaal et al. 2017 [306] CH Cross-national Health Services 1 6
Schmidt et al. 2010 [307] DK National Public Health; Other 0 4
Schmidt et al. 2010b [308] DK National Public Health 0 8
Schmidt et al. 2011 [309] DK National Public Health 0 4
Schmidt et al. 2012 [310] DK National Public Health 0 5
Schmidt et al. 2012b [311] DK National Public Health 2 5
Schmidt et al. 2014 [312] DK National Public Health; Other 1 11
Schmidt et al. 2018 [313] DK National Health Services 1 11
Schneeberger et al. 2013 [314] Both Cross-national Health Services 0 3
Schoos et al. 2015 [315] DK National Public Health; Other 0 4
Schroll et al. 2012 [316] DK National Health Services 1 4
Schuemie et al. 2012 [317] DK Cross-national Health Services; Public Health 2 6
Sejbaek et al. 2013 [318] DK National Public Health; Research 0 4
Skyum et al. 2018 [319] DK National Health Services; Other 3 4
Skyum et al. 2019 [320] DK Cross-national Health Services; Research 2 7
Soerensen et al. 2014 [321] DK National Health Services; Public Health 1 7
Sommer et al. 2018 [322] CH National Research 2 6
Sørensen et al. 2009 [323] DK National Public Health 1 1
Sørensen et al. 2013 [324] DK National Health Services; Public Health 1 6
Spoerri et al. 2010 [325] CH National Public Health 1 3
Stahl Madsen et al. 2014 [326] DK National Health Services 0 3
Steenholdt et al. 2014 [327] DK National Public Health; Research 1 6
Stewardson et al. 2016 [328] CH Cross-national Health Services 1 9
Strasser et al. 2016 [329] CH National Research 1 7
Streit et al. 2014 [330] CH National Health Services 2 4
Strnad et al. 2016 [331] CH Cross-national Research 0 6
Stukalin et al. 2018 [332] DK Cross-national Health Services; Public Health 1 3
Su¨rder et al. 2013 [333] CH National Research 1 4
Suttorp et al. 2018 [334] CH Cross-national Research 0 6
Svendsen et al. 2013 [335] DK National Health Services; Public Health 0 2
Talman et al. 2008 [336] DK National Health Services; Public Health 0 3
Thillemann et al. 2009 [337] DK National Public Health 0 4
Thomsen et al. 2008 [338] DK National Health Services; Public Health 0 5
Thornqvist et al. 2014 [339] DK National Health Services; Public Health 2 6
Thøstesen et al. 2015 [340] DK National Public Health; Research; Other 0 4
Thygesen et al. 2011 [341] DK National Health Services; Public Health 0 5
Tollånes et al. 2016 [342] DK Cross-national Health Services; Public Health; Research 2 7
Trabert et al. 2014 [343] DK Cross-national Research 4 4
Tutolo et al. 2019 [344] CH Cross-national Health Services 1 3
Tvedskov et al. 2011 [345] DK National Health Services; Public Health 2 5
Tvedskov et al. 2015 [346] DK National Health Services; Public Health 1 5
(Continued)
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Overview of barriers
Barriers of an ethical nature were reported 19 times in the included records and they con-
cerned mainly issues related to privacy (n = 9) and respect for autonomy of study participants
(n = 6) (Table 3). As to legal barriers, these were reported 17 times and they included issues
associated with national data protection regulations (n = 4), differences in national legislations
concerning data security and privacy (n = 4) and “Other” (n = 9) (e.g. legal uncertainty con-
cerning health data collection or sharing, market restriction, etc.). Overall, the type of barriers
that were more often reported, however, were those of a technical nature. In the records, 416
technical barriers were mentioned and they were classified as data quality issues (e.g. data
incompleteness, potential misclassification of data, etc.) (n = 234), lack of data standards (data
structure and semantics, e.g. ambiguous terminologies, temporal evolution of data standards,
etc.) (n = 151), limited technical capabilities (e.g. no unique identifier, etc.) (n = 21) and
“Other” (n = 10) (e.g. time constraints on physicians preventing the use of standard proce-
dures for data collection). Financial barriers were also reported, but only a limited amount of
times (n = 9), and they were principally referring to the unavailability or inadequacy of
Table 2. (Continued)
Reference Country Partnership
Type
Source of health data Total Identified Barriers,
n
Total Identified
Facilitators, n
Ulff-Moller et al. 2018 [347] DK National Health Services; Public Health; Research;
Other
2 6
Underbjerg et al. 2013 [348] DK National Health Services; Public Health 2 6
Underbjerg et al. 2015 [349] DK National Public Health 0 5
Ungaro et al. 2019 [350] DK Cross-national Public Health 3 6
Usvyat et al. 2013 [351] Both Cross-national Health Services 8 4
Vach et al. 2018 [352] CH National Health Services; Research; Other 2 4
Van Hedel et al. 2018 [353] CH Cross-national Health Services 3 7
Van Stralen et al. 2011 [354] Both Cross-national Research 1 3
Vasan et al. 2016 [355] DK Cross-national Public Health 0 5
Vester-Andersen et al. 2014 [356] DK National Health Services; Public Health 0 6
Vest-Hansen et al. 2014 [357] DK National Public Health 1 5
Viberg et al. 2018 [358] DK National Health Services; Public Health 0 5
Villadsen et al. 2011 [359] DK National Health Services; Public Health 2 3
Walters et al. 2013 [360] DK Cross-national Public Health 5 4
Weber et al. 2013 [361] CH National Health Services 11 5
Weigang et al. 2010 [362] CH Cross-national Health Services 1 3
Wiegand et al. 2014 [363] CH Cross-national Research 1 6
Wildgaard et al. 2011 [364] DK National Health Services; Public Health 1 2
Winterfeld et al. 2013 [365] Both Cross-national Health Services 1 4
Wurtzen et al. 2013 [366] DK National Health Services; Research 0 6
Ylijoki-Sorensen et al. 2014 [367] DK Cross-national Public Health 4 4
Zalfani et al. 2012 [368] CH National Health Services; Public Health 0 4
Zecca et al. 2018 [369] CH National Health Services 2 4
Zellweger et al. 2014 [370] CH National Health Services; Other 2 5
Zellweger et al. 2019 [371] CH National Public Health 1 5
Zwisler et al. 2016 [372] DK National Health Services; Public Health 0 10
a DK: Denmark
b CH: Switzerland
https://doi.org/10.1371/journal.pone.0226015.t002
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financial support (n = 8). Only 13 political barriers were found and they comprised institu-
tional/constitutional organization issues (e.g. federalist system and different healthcare sys-
tems) (n = 6), mistrust between stakeholders (n = 3), data ownership issues (n = 2) and
“Other” (n = 2) (e.g. no official guidelines for data sharing). Studies also reported some moti-
vational barriers, including lack of research incentives (n = 17) (including additional workload
imposed on physicians/researchers), data re-use prevented by stakeholders as they are deemed
unfit for secondary use (n = 2), stakeholders’ competing interests (n = 2) and additional barri-
ers of a diversified content, thus labelled as “Other” (n = 4) (e.g. study participants not showing
up for part of the study). Finally, 6 socio-cultural barriers were reported in the included rec-
ords, half of which were related to a “cultural clash” (n = 3), which we defined as issues result-
ing from different cultures in data collection, sharing and linkage of the partners involved in
the project.
Table 3. Distribution of barriers’ sub-clusters in national and cross-national Danish and Swiss projects.
Barriers Countries involved in projects
Cluster Sub-cluster Denmark Na = 251 Switzerland N = 80 Both countries N = 14
nb (mean no. of barriers per
project)
n (mean no. of barriers per
project)
n (mean no. of barriers per
project)
Ethical Privacy 6 (0.02) 3 (0.04) -c (N/A)
Respect for Autonomy 3 (0.01) 3 (0.04) - (N/A)
Other 3 (0.01) 1 (0.01) - (N/A)
Legal Data Protection Regulations 2 (0.01) 1 (0.01) 1 (0.07)
Divergence in National Legislations for Data Security and
Privacy
2 (0.01) - (N/A) 2 (0.14)
Other 5 (0.02) 3 (0.04) 1 (0.07)
Technical Lack of Data Standards 104 (0.41) 33 (0.41) 14 (1.00)
Data Quality Issues 181 (0.72) 44 (0.55) 9 (0.64)
Limited Technical Capabilities 11 (0.04) 9 (0.11) 1(0.07)
Other 8 (0.03) 2 (0.03) - (N/A)
Financial Lack of Funding 4 (0.02) 3 (0.04) 1 (0.07)
Other 1 (0.00) - (N/A) - (N/A)
Political Mistrust between stakeholders - (N/A) 3 (0.04) - (N/A)
Data Ownership 2 (0.01) - (N/A) - (N/A)
Institutional/constitutional organization issues 2 (0.01) 4 (0.05) - (N/A)
Other - (N/A) 2 (0.03) - (N/A)
Motivational Lack of research incentives 6 (0.02) 9 (0.11) 2 (0.14)
Stakeholder restricts access for re-use of data as deemed
unfit for secondary use
2 (0.01) - (N/A) - (N/A)
Stakeholder competing interests 1 (0.00) 1 (0.01) - (N/A)
Other 1 (0.00) 3 (0.04) - (N/A)
Sociocultural Cultural clash for data collection/sharing/linkage 1 (0.00) 2 (0.03) - (N/A)
Other 1 (0.00) 2 (0.03) - (N/A)
Table 3 shows the distribution of barriers’ sub-clusters in national and cross-national Danish and Swiss projects. As such, single-country and multi-national countries
are not differentiated.
a N is the total number of projects in each country category
b n is the total number of reported barriers per sub-cluster
c–is the absence of reported barriers per sub-cluster
N/A–Not Applicable
https://doi.org/10.1371/journal.pone.0226015.t003
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Overview of facilitators
Facilitators of an ethico-legal nature were reported 582 times in total, and they were classified as
official/legal approval of study (e.g. Danish Data Protection Agency) (n = 148), ethical approval by
a REC/IRB (n = 135), legislation permitting to proceed with health data collection, sharing and
linkage without consent or REC/IRB approval (n = 79), obtaining informed consent from partici-
pants (n = 69), health data anonymization (n = 58), the presence of legislation requiring mandatory
reporting (n = 41), confidentiality measures (n = 29; e.g. data security audits), project done accord-
ing to international laws and regulations (n = 8), data access rights for patients (n = 4), clear legisla-
tion for data collection, sharing or linkage (n = 3) and “Other” (n = 8) (e.g. study data made
available by researchers upon request). Facilitators of a technical nature were reported 981 times in
total, which were grouped in three categories, namely techniques for data harmonization (n =
798), data linkage (n = 155) and “Other” (n = 28) (e.g. study allowed the creation of optional and
mandatory datasets, whereby a minimum of data are classified as mandatory). Facilitators of a
financial nature, especially explaining how funding was successfully secured, were mentioned 12
times. These referred, for example, to public-private partnerships, where both partners would gain
some benefits from the collaboration, as a solution for funding issues (n = 3). 169 facilitators related
to politics were reported. These referred to the structure of the health system as an advantage for
harmonized health data collection, sharing and linkage (n = 139), data access control by the players
(n = 11), the presence of a data sharing agreement between the stakeholders (n = 9), building and
maintaining stakeholders’ trust for collaboration (n = 7) and “other” (n = 4). There were 14 moti-
vational facilitators, which included monetary incentives to incite researchers/stakeholders to
abide by standardized procedures for data handling and management (n = 7), improved data col-
lection tool to ease the workload of researchers/stakeholders for data collection/sharing (n = 3), a
memorandum of understanding between partners to ensure collaboration till end of study (n = 2)
and “other” (n = 2). Lastly, there were 8 socio-cultural facilitators, which included data subjects
controlling access to their data (n = 4) and “Other” (n = 4) (e.g. transparent policies for the partici-
pants). Country-wise distribution for all six facilitators categories are presented in Table 4.
Barriers and facilitators identified in national Danish and Swiss projects
When considering only national projects (n = 240) involving either Denmark (N = 200) or
Switzerland (N = 40) alone, there were 323 identified barriers and 1234 facilitators. Technical
barriers and facilitators were most frequently reported. For comparison purposes and com-
pensation for the imbalances in the number of national projects identified in each country, the
absolute numbers and the number of barriers and facilitators per 1,000 national projects for
each country are illustrated in Table 5.
Interestingly, the only identified category of barriers which was comparatively almost
equally reported in Swiss and Danish single-country projects was that of technical barriers.
Otherwise, ethical, legal, financial, motivational and socio-cultural barriers were reported 5.0,
3.3, 3.3, 5.7 and 10.0 times more in Swiss projects than in Danish projects respectively. On the
contrary, a Swiss project reported on average more facilitators than a Danish one (only finan-
cial facilitators were reported equally in both countries). Ethico-legal, technical, motivational
and socio-cultural facilitators were reported 1.2, 1.3, 4.2 and 1.3 times more in Swiss projects
than in Danish projects respectively. Only facilitators related to politics were reported 4.5
times more in Danish projects than Swiss projects.
Barriers and facilitators identified in cross-national Danish and Swiss projects
With respect to cross-national projects (n = 105), there were 182 identified barriers and 532
identified facilitators. Technical barriers and facilitators were more frequently reported than
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those of another nature. For comparison purposes and compensation for the imbalances in the
number of cross-national projects involving each country, the number of barriers and facilita-
tors per 1,000 cross-national projects was calculated (excluding cross-national projects involv-
ing both countries) and illustrated in Table 6.
Table 4. Distribution of facilitators’ sub-clusters in national and cross-national Danish and Swiss projects.
Facilitators Countries involved in projects
Cluster Sub-cluster Denmark Na = 251 Switzerland N = 80 Both countries N = 14
nb (mean no. of facilitators
per project)
n (mean no. of facilitators
per project)
n (mean no. of facilitators
per project)
Ethico-
Legal c
Ethical approval by REC/IRB 73 (0.29) 55 (0.69) 7 (0.50)
Health Data Anonymization 31 (0.12) 22 (0.28) 5 (0.36)
Obtaining informed Consent 29 (0.12) 34 (0.43) 6 (0.43)
Patient data access rights 3 (0.01) 1 (0.01) -d (N/A)
Confidentiality measures taken 22 (0.09) 6 (0.08) 1 (0.07)
Clarity of legislation for health data collection/
sharing/linkage
2 (0.01) 1 (0.01) - (N/A)
Official/legal approval of project 140 (0.56) 7 (0.09) 1 (0.07)
Project done according to international laws and
regulations
6 (0.02) 1 (0.01) 1 (0.07)
Legislation allows project without consent or REC
approval
66 (0.26) 12 (0.15) 1 (0.07)
Legislation requires mandatory reporting 40 (0.16) 1 (0.01) - (N/A)
Other 6 (0.02) 2 (0.03) - (N/A)
Technical Data harmonization techniques 488 (1.94) 251 (3.14) 59 (4.21)
Data Linkage techniques 146 (0.58) 6 (0.08) 3 (0.21)
Other 24 (0.10) 3 (0.04) 1 (0.07)
Financial Securing funding 6 (0.02) 1 (0.01) 1 (0.07)
Public-Private partnership 1 (0.00) 2 (0.03) - (N/A)
Other 1 (0.00) - (N/A) - (N/A)
Political Data Sharing Agreement 1 (0.00) 5 (0.06) 3 (0.21)
Building and maintaining stakeholder trust 1 (0.00) 4 (0.05) 2 (0.14)
Data access control 9 (0.04) 2 (0.03) - (N/A)
Health System Structure 138 (0.55) 1 (0.01) - (N/A)
Other 3 (0.01) - (N/A) - (N/A)
Motivational Monetary Incentive 5 (0.02) 2 (0.03) - (N/A)
Easing workload through improvement of data
collection
1 (0.00) 2 (0.03) - (N/A)
Memorandum of understanding to ensure
collaboration until end of study
- (N/A) 2 (0.03) - (N/A)
Other - (N/A) 1 (0.01) 1 (0.07)
Sociocultural Participant data access control 2 (0.01) 1 (0.01) 1 (0.07)
Other 4 (0.02) - (N/A) - (N/A)
Table 4 shows the distribution of facilitators’ sub-clusters in national and cross-national Danish and Swiss projects. As such, single-country and multi-national countries
are not differentiated.
a N is the total number of projects in each country category
b n is the total number of reported facilitators per sub-cluster
c Ethical and legal facilitators were merged as reported solutions had both an ethical and a legal dimension
d–is the absence of reported facilitators per sub-cluster
N/A–Not Applicable
https://doi.org/10.1371/journal.pone.0226015.t004
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Concerning cross-national projects, we observed a reverse tendency as compared to
national projects. Studies involving a collaboration with a Swiss partner have, on average,
reported 1.8 times less barriers than those involving a Danish partner. More in detail, projects
including Switzerland reported 4.7, 1.9, 1.6, 3.1 times less barriers of an ethical, technical,
financial and political nature respectively, than those with a Danish partner. However, cross-
national projects involving a Swiss partner, reported 2.1 times more barriers of a motivational
nature than those with a Danish partner. Comparatively, cross-national collaboration involv-
ing either a Swiss or Danish partner reported almost the same number of facilitators. Ethico-
legal and political facilitators were identified 1.1 and 2.4 times more in cross-national projects
with a Danish partner as opposed to cross-national projects involving a Swiss one. However,
Table 5. Distribution of barriers and facilitators in national Danish and Swiss projects.
Barrier
category
Denmark Na = 200 Switzerland N = 40 Facilitator
category
Denmark N = 200 Switzerland N = 40
nb (no. of barriers per 1,000
projects)
n (no. of barriers per 1,000
projects)
n (no. of facilitators per 1,000
projects)
n (no. of facilitators per 1,000
projects)
Ethical 6 (30) 6 (150) Ethico-legal 331 (1655) 82 (2050)
Legal 6 (30) 4 (100)
Technical 216 (1080) 51 (1275) Technical 523 (2615) 132 (3300)
Financial 3 (15) 2 (50) Financial 8 (40) 2 (40)
Political -c (N/A) 8 (200) Political 134 (670) 6 (150)
Motivational 7 (35) 8 (200) Motivational 6 (30) 5 (125)
Sociocultural 2 (10) 4 (100) Sociocultural 4 (20) 1 (25)
Total 240 83 Total 1006 228
Mean 1.20 2.08 Mean 5.03 5.70
a N is the total number of projects in each country category
b n is the total number of identified barriers or facilitators per cluster
c–is the absence of identified barriers and facilitators per cluster
N/A–Not Applicable
https://doi.org/10.1371/journal.pone.0226015.t005
Table 6. Distribution of barriers and facilitators in cross-national Danish and Swiss projects.
Barrier
category
Denmark Na = 51 Switzerland N = 40 Both
countries
N = 14
Facilitator
category
Denmark N = 51 Switzerland N = 40 Both
countries
N = 14
nb (Number of
barriers per 1,000
projects)
n (Number of barriers
per 1,000 projects)
n (Number of
facilitators per 1,000
projects)
n (Number of
facilitators per 1,000
projects)
Ethical 6 (118) 1 (25) - c Ethico-legal 87 (1706) 60 (1500) 22
Legal 3 (59) - (N/A) 4
Technical 88 (1725) 37 (925) 24 Technical 135 (2647) 128 (3200) 63
Financial 2 (39) 1 (25) 1 Financial - (N/A) 1 (25) 1
Political 4 (78) 1 (25) - Political 18 (353) 6 (150) 5
Motivational 3 (59) 5 (125) 2 Motivational - (N/A) 2 (50) 1
Sociocultural - (N/A) - (N/A) - Sociocultural 2 (39) - (N/A) 1
Total 106 45 31 Total 242 197 93
Mean 2.08 1.13 2.21 Mean 4.75 4.93 6.64
a N is the total number of projects in each country category
b n is the total number of identified barriers or facilitators per cluster
c–is the absence of identified barriers and facilitators per cluster
N/A–Not Applicable
https://doi.org/10.1371/journal.pone.0226015.t006
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technical facilitators were identified 1.2 times more in cross-national projects with a Swiss
partner than in those with a Danish one.
Discussion
This systematic review provides a comprehensive overview of projects from either Denmark
or Switzerland which involved the collection, linking or sharing of data and of the barriers and
facilitators related to the usage of health data therein reported. Our study includes a broad
range of projects relying on data from different sources and contexts (health services, public
health, research and other) and it confirms that studies involving the harmonization, linking
or sharing of health data still encounter a high number of obstacles, but also underscores that
barriers have prompted the development of numerous solutions. We will here address and dis-
cuss the findings related to barriers and facilitators of each cluster that was identified.
Ethico-legal barriers and facilitators
Although ethico-legal factors are often described as some of the most problematic elements
when it comes to linking and sharing health-related data [9, 373, 374], our results show that
barriers of this nature are rarely reported. The small amount of ethico-legal barriers identified
might either mean that such barriers were rarely present or that they were present but underre-
ported. In our view, the latter option is more probable for at least two reasons. Firstly, as the
records included in this review were all published articles, the explicit mentioning of ethico-
legal complications might have been avoided to bypass problems related to publication. Sec-
ondly, ethico-legal factors are often less tangibile and transparent in comparison–for example–
with technical ones [15] and they are thus more likely to be superseded. Moreover, underre-
porting would confirm that ethico-legal aspects related to processing of health data are still
underappreciated, which is a major obstacle to the final success of research projects [2]. This
also suggests that there is some resistency by authors to openly disclose and discuss ethico-
legal problematics. For the future, a less cautious approach would be much more beneficial,
since it would allow new research projects to build on the issues encountered by old ones.
Ethico-legal facilitators were more widely mentioned. Results show that Swiss projects are
still predominantly anchored to the “consent or anonymise” approach, according to which the
solution to solve ethico-legal problematics concerning health data is to either anonymize infor-
mation or to require explicit authorization by data subjects [1]. Differently, Danish projects
have made vaster use of alternative solutions, such as relying on specific confidentiality tools,
and, more importantly, exploiting regulation that allows—upon certain conditions—to share
and link health-related data without the need of obtaining consent by data subjects or REC
approval. This demonstrates that the development of proper regulations to facilitate the
harmonization and linking of health data offers practical solutions that projects developers are
then willing to use. In this framework, another important finding concerns the role of the data
protection authority. Whereas in Switzerland this public office–although existing–does not
play a defined role with respect to research, results show that Danish studies have a more active
interaction with the Data Protection Agency, as they need to apply for permission to use health
data. The nature of the application to the national Data Protection Agency that Danish projects
need to file is not explicitly described in the records reviewed, but it has been presented else-
where [375, 376] as a less demanding procedure, resembling a simple duty of notification.
Thus, many Danish projects dealing exclusively with health data–in accordance with national
regulation–do not need to apply for full ethical review from a REC or IRB, an often demanding
and lengthy process, but simply have to obtain clearance from the Data Protection Agency.
This institutionalized interaction with the public authority responsible to ensure compliance
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with data processing rules can be an important factor helping project developers, since it
incentivizes to proactively tackle privacy concerns. This interaction could thus be considered
as a model to inspire changes in the regulatory framework in Switzerland.
Technical barriers and facilitators
In this systematic review, data quality issues were the most commonly reported barriers, fol-
lowed by the lack of data standards and limited technical capabilities. Although Denmark has
a developed health data infrastructure, numerous identified projects described that data quality
problems still affect health services, public health and research datasets [38, 79, 86, 98, 119,
143, 149, 151]. This is confirmed by other studies, such as a review on the Danish National
Patient Registry (DNRP) where the authors concluded that data incompleteness and heteroge-
neous validation methods of data limited the research potential of this registry [377]. Although
relevant, data quality issues can be mitigated in a system like the Danish one, since linkage
between data from different registries can be easily performed using the personal identification
number (CPR) provided to all Danish citizens at birth and to stable residents [270]. Compara-
tively, Swiss projects and projects involving a Swiss partner also reported slightly more issues
related to data quality than to data standards. However, in comparison to their Danish coun-
terparts which reported almost twice more issues related to data quality than data standards,
the difference in reporting of data standards and data quality issues was smaller in Swiss proj-
ects. This more equivalent reporting could imply that data standard issues are considered as
important as data quality issues for the success of Swiss projects. Indeed, the high levels of
data-heterogeneity in the Swiss healthcare context might stem from the fragmented nature of
the healthcare system, where each of the 26 cantons [federal states] has a high degree of auton-
omy and where more than 55 health insurers are active [378].
These findings underline how technical issues are interconnected with the context where
projects are carried out, and that also external systemic factors–and not simply internal com-
plications of the projects themselves—affect the emerging of these barriers. In Denmark, for
example, the presence of nation-wide registries fosters the development of studies relying on
secondary use of routinely collected data, where researchers are more likely faced with issues
about the quality of data, since the latter was originally collected for a different purpose. On
the contrary, in a country like Switzerland—where data are more often prospectively collected
—issues about the absence of common standards because of fragmentation are also likely to be
evident, on top of data quality issues.
Our findings suggest therefore that even technical issues concerning data are strongly
embedded in the surrounding where projects are conceived. This should induce project devel-
opers to communicate and learn from each others, since the barriers they will encounter and
the solutions they will find are more likely to be dependent also on the context where they act,
and not only on the specific features of their research. For example, since Switzerland’s health-
care sector does not use a universal personal identification number because of privacy con-
cerns [379], linkage of data will almost certainly represent a technical challenge, regardless of
the features the single project or the data that it aims at using.
Motivational and financial barriers and facilitators
With respect to motivational and financial factors, our findings are partly in line with the liter-
ature. Previous research had underscored that the key motivational and financial aspects con-
cerned the lack of research incentives from resource-limited institutions, the fears of being
‘robbed’ of data before publication or of losing reputation because others might identify errors
in the data, the reluctance to facilitate access due to potential inappropriateness of further uses,
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the need to secure resources for data sharing activities and the necessity to make arrangements
between institutions for data management costs [15, 380, 381].
Overall, national and cross-national Swiss projects combined reported more frequently
motivational and financial facilitators than their Danish counterparts. This suggests that in a
country with a less institutionalised system of data sharing and where studies often have a pro-
spective design, more strategies are elaborated to deal with financial and motivational issues
related to data, since–with a lower systemic support–single project developers have to make a
greater effort. In contrary, in a context like Denmark—with the high prevalence of studies
with retrospective design and the reliance on secondary uses of routinely collected health
data–the need for financial and motivational facilitators might be lower. In fact, when health
data harmonization is prevalently retrospective, a lower number of actors is involved [382]–
since primary data collectors are rarely included–thus reducing the urgency to create motiva-
tional or financial incentives for a large number of collaborators.
Another important finding related to financial aspects is that the presence of economic con-
straints can be the source of additional barriers related to data harmonization, such as data
quality issues. For instance, the Swiss project AMIS Plus—concerning a register for acute coro-
nary syndrome—could not envisage systematic site visits to assess data quality or more in-
depth questionnaires due to resource limitation [290]. In Denmark, similarly, with the Copen-
hagen School Health Records Register—a health examination register for schoolchildren con-
taining data on more than 350,000 individuals—financial constraints made it impossible for
the authors to computerize the entire health card, thus limiting the understanding of potential
confounding variables [47]. This indicates even more that barriers of different natures are
interconnected and that new projects need to acknowledge this interconnectedness of the bar-
riers to successfully address them.
Political barriers and facilitators
Danish national projects did not report any barriers of a political nature, whereas cross-
national collaborations mentioned a few, such as data ownership and organizational issues
[44, 85, 95]. This suggests that an institutionalization of data processing practices, similar to
what occurs in Denmark [383], helps to remove political obstacles. Moreover, the presence of
a centralized healthcare system structure also proves helpful, because it reduces the number of
actors involved and thus the presence of competing interests. Political issues, however, might
re-emerge when projects are cross-national and thus abandon the relatively safe-haven created
at the national level.
In a context like the Swiss one, on the contrary, political barriers seem to be more relevant
for national projects, because these fuel internal conflicts related to the diversity of interests
within healthcare and to the difficulty of implementing uniform and centralized policies [132].
In fact, the two most mentioned political facilitators in Switzerland–building trust amongst
stakeholders [132, 361] and stakeholders retaining control over data access [132, 290]–are
both related to the attempt to coordinate the numerous different parties operating in the health
data field and accommodate their competing interests. This might also explain why less politi-
cal barriers are reported for Swiss cross-national projects. In fact, when projects from a context
like the Swiss one go to a supra-national level, the chances of disputes related to in-country
political antagonism to emerge is lower.
Our results are thus in line with the literature, where mistrust between stakeholders,
absence of comprehensive guidelines for data sharing and lack of legal accountability were
identified as major political issues [2, 7, 15]. However, our results further show that the inci-
dence of political barriers seems quite different in single-country studies if compared to cross
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national ones. This finding is particularly important since it underlines that sometimes the
choice of a national or cross-national design might have an impact on the number of political
issues encountered.
Socio-cultural barriers and facilitators
Barriers and facilitators of a socio-cultural nature were rarely mentioned in the included records.
Comparatively, the incidence of cultural barriers seems to be higher for Switzerland, where cul-
tural clashes were mentioned more often than for Danish projects. Such difference could be due
to the higher degree of fragmentation of the Swiss healthcare system in comparison to the Danish
one, which is centralized and state-funded [18]. In fact, one Swiss study [132] reported that the
choice for a distributed model in the managing of data was based on prior failures to implement
centralized systems of health data and public mistrust towards the concept of centralization.
Socio-cultural facilitators were mostly related to the involvement of data-subjects by allowing
them to retain control of data access. For instance, the Swiss project reported that data subjects
had the possibility to decide which part of their medical records could be considered “stigmatiz-
ing”, and thereafter blinded to healthcare professionals, other than their designated and trusted
physician [132]. The designated and trusted physician would have access to the full record.
It is naturally impossible to determine whether socio-cultural barriers were actually over-
looked or simply not reported. In either case, the limited mentioning of these factors signals
an underappreciation of their importance. On the contrary, socio-cultural aspects should be
carefully considered by project developers, since the harmonization of health data cannot
ignore the cultural peculiarities of the single contexts from where data are pooled [384].
Harmonization, linking and sharing do not happen in a vacuum and opening up the dialogue
between data processors and society at large can be an important success factor for the harmo-
nization of health data in the long run.
Limitations
The limitations of this systematic review include choices that we made regarding the number
of databases used for our search, the fact that we did search using English key words, and that
only 20 percent of included papers went through double checking for data extraction consis-
tency. We could have thus missed valuable studies that were published only in Danish, French,
and German which we could have found if key words had been in those languages. Given the
high number of papers included and resources related constraints, we were unable to double
check for all information recorded, but in light of low discrepancies found in the portion of
records which were double-checked, we are confident in our output. A reporting bias of barri-
ers and facilitators identified in the included papers cannot be excluded as published papers
are focused mostly on the effectiveness of their interventions rather than on the implementa-
tion phase. It is possible that our results are thus biased towards barriers and facilitators more
likely to be reported in the papers (e.g. those of a technical nature). Given the low numbers of
certain types of reported barriers and facilitators, it is difficult to compare the situation in the
two countries without under- or over-exaggerating their presence or absence in the two coun-
tries. However, the main objective of this systematic review was to identify barriers and facili-
tators to harmonized health data collection, sharing and linkage in Denmark and Switzerland.
Causal inference was not part of this review’s primary objectives.
Conclusion
This systematic review gathered evidence from Switzerland and Denmark to map and describe
barriers and facilitators concerning data harmonization, sharing and linkage. Given the focus
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of this review on Switzerland and Denmark, part of the findings has specific relevance for these
two countries. In particular, for Switzerland it has emerged that fragmentation in the health
data environment is a key challenge for harmonizing, sharing and linking of data. Since the
implementation of more centralized governance systems—which are of great use in Denmark
—might not be a viable option for Switzerland because of the political structure of the country,
a distributed governance model, which emphasises interoperability of health data, seems to be
the preferable way forward. The introduction of Blockchain technology for patient records,
which insures security and respects decentralization [385, 386], is reportedly an auspicious tech-
nology as its use in the Estonian healthcare system described by Mettler [387] suggests. This
review outlined that the existing data infrastructure at the national-level in Denmark incentiv-
izes the completion of retrospective registry-based studies relying on data reuse. Although barri-
ers are still reported, the existence and comprehensiveness of this data infrastructure confirms
that past efforts to improve the health data framework have proven successful. For the future,
efforts should focus on easing projects involving cross-national collaborations.
However, other findings are meaningful well beyond the borders of the two countries spe-
cifically considered. In particular, in this review it has emerged that, although a great number
of barriers and facilitators are mentioned by the projects involving health data harmonization,
sharing and linking, reporting focusses predominantly on specific aspects–above all technical
ones. Whereas technical aspects are certainly important, the reluctancy to mention also issues
of other natures is detrimental to the more general effort of the scientific community to favour
the harmonization of health data. Referring more openly to the difficulties encountered at the
ethico-legal level, for example, might be of help both for new projects to develop appropriate
approaches and for policy makers to gather evidence on which regulatory interventions are
needed. The under-appreciation of ethico-legal, socio-cultural and other context-specific com-
plexities is a faux-pas, since the trust of both data-subjects and society at large is indispensable
for the success a community in improving the health data context, like the experience of Ice-
land has demonstrated in the past [388]. There, the project to build a national “health sector
database” with health information of all citizens imported from their medical records failed
also due to the underappreciation of ethico-legal issues (e.g. informed consent and privacy).
Specifically, the population complained that inclusion of personal medical records into the
database was supposed to happen without consent by individuals or the possibility to opt out.
This was felt like a violation of privacy, because of the risk of re-identification and also due to
the fact that the database was supposed to be run by a private company [389]. A privacy com-
plaint was brought in front of the national high court, who ruled against the project to build
the database. For this reason, the project was definitely aborted [390].
In summary, the success of current and future projects is likely to depend on a better under-
standing and appreciation of the complexities associated with harmonizing, sharing and linking
health data. In the same line, proposed solutions to harmonization issues should not underesti-
mate the contextual particularities of the country, in which such health data processes occur.
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